Skip to main content
Premium Trial:

Request an Annual Quote

Debiopharm Group Taps Quartz Bio to Provide Bioinformatics Support for Biomarker Projects

Premium

Last week, Quartz Bio said that it had been selected to provide bioinformatics support for biomarker projects conducted by the Debiopharm group, a Swiss-based biopharmaceutical company.

Under the terms of the one-year agreement, the Merck Serono spinoff (BI 9/7/2012) will provide computational analyses for Debiopharm projects in areas such as preclinical next-generation sequencing and clinical biomarker data analyses.

The financial details of the deal are not being disclosed.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.